Ezetimibe tablet bulk supplier for pharma manufacturers

Ezetimibe Tablet 10 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 10 mg

Reference Brands: Zetia(US), Ezetrol(EU)

Ezetimibe inhibits intestinal absorption of dietary and biliary cholesterol by blocking the NPC1L1 transporter. It significantly lowers LDL cholesterol, supports cardiovascular health, and reduces atherosclerosis risk. Benefits include effective cholesterol management, often combined with statins for enhanced lipid lowering and improved long-term heart health outcomes.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Ezetimibe Tablet? List it or send an offer →

Product Description: Ezetimibe tablets, marketed as Zetia in the US and Ezetrol in the EU, are approved for lowering LDL cholesterol by inhibiting intestinal absorption. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality information, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports timely approval, safe use, and global availability, enabling effective lipid management and cardiovascular risk reduction worldwide.

Ezetimibe Tablet — third party manufacturing & bulk supply

Ezetimibe Tablet 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ezetimibe Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ezetimibe Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ezetimibe Tablet →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Ezetimibe tablet is listed as Tablet in 10 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ezetimibe tablet is referenced against Zetia(US), Ezetrol(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.